Based on the clinical features, the results of the brain MRI, and Aβ42, P-tau, and T-tau levels in the CSF, the patient was diagnosed with AD with parkinsonian and psychiatric features (Fig. 1A, 1C). The gene discussed is MAPT; the disease is Alzheimer disease.